Myriad Genetics
MYGN
#7319
Rank
A$0.79 B
Marketcap
A$8.25
Share price
-1.44%
Change (1 day)
-17.39%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): A-$1.97

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is A-$2.05. In 2025 the company made an earnings per share (EPS) of A-$5.95 a decrease over its 2024 EPS that were of A-$2.13.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.97-66.95%
2025A-$5.95179.43%
2024A-$2.13-55.94%
2023A-$4.83130.22%
2022A-$2.10275.68%
2021A-$0.56-87.99%
2020A-$4.65755.56%
2019A-$0.54-194.74%
2018A$0.57-79.89%
2017A$2.86112.36%
2016A$1.34-35.97%
2015A$2.10-7.33%
2014A$2.27-37.24%
2013A$3.6159.33%
2012A$2.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
A$4.09-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
A-$8.04 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$76.90 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$57.65-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA